About CellSearch
CellSearch is a company based in Raritan (United States) founded in 2012 was acquired by Silicon Biosystems in December 2016. The company has 67 employees as of December 31, 2021. CellSearch has completed 1 acquisition, including Immunicon. CellSearch operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Raritan, United States
- Employees 67 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Menarini Silicon Biosystems, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
67
as on Dec 31, 2021
- Investments & Acquisitions
-
Acquired by
Silicon Biosystems
(Dec 20, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CellSearch
Detailed funding history for CellSearch
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in CellSearch
CellSearch has secured backing from 1 investor. Prominent investors backing the company include Silicon Biosystems.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
Locked | Locked | Locked |
Investor details for CellSearch
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CellSearch
CellSearch has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Immunicon.
Investment portfolio details for CellSearch
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cell and molecular-based diagnostics for cancer management are developed.
|
Locked | Locked | 1983 | Locked |
Complete acquisition details for CellSearch
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - CellSearch
Detailed financials for CellSearch
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellsearch Comparisons
Peer comparison for CellSearch
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CellSearch
CellSearch operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of CellSearch
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellsearch
Complete news archive for CellSearch
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CellSearch
CellSearch was founded in 2012.
CellSearch is headquartered in Raritan, United States. It is registered at Raritan, New Jersey, United States.
As of Dec 31, 2021, the latest employee count at CellSearch is 67.
Founded in 2012 and based in Raritan, United States, operations focus on the healthcare sector, specifically oncology diagnostics. Blood tests are provided through the CellSearch System, which utilizes immunomagnetic capture and fluorescence imaging to identify circulating tumor cells of epithelial origin. This technology is applied to assess prognosis and survival outcomes for patients with metastatic breast, colorectal, or prostate cancer during treatment monitoring.
CellSearch's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
CellSearch has made 1 acquisition, including Immunicon.
CellSearch has 1 investor. Key investors include Silicon Biosystems.